Beating melanoma with drug discovery, immunotherapy and cutting-edge science

Source: ICR.AC.UK, October 2019

Looking down a large, state-of-the-art microscope in The Institute of Cancer Research’s Chelsea laboratories, Dr Chris Bakal explains how technology is giving his team an unprecedented understanding of how cancer cells grow and spread.

Dr Bakal works on a skin cancer called melanoma – the fifth most common cancer in the UK, with around 16,000 newly diagnosed cases each year.

Scientists at the ICR have long been at the forefront of research to better understand melanoma, and our research is behind the discovery of some of the most important new treatments for the disease.

Read the original full article